Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet 2025-07-29 at 21:04 By Cointelegraph by Sam Bourgi The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders. This article is an excerpt from Cointelegraph.com News View […]
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet Read More »